{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:58:26Z","timestamp":1790693906053,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lanmic.2026.101514","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:09:49Z","timestamp":1790161789000},"page":"101514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial resistance surveillance: a crucial pillar for sustainable leprosy control and chemoprophylaxis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8495-8227","authenticated-orcid":false,"given":"Anil","family":"Fastenau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Avanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimer","family":"Ortu\u00f1o-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Marijke Braet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1475-9915","authenticated-orcid":false,"given":"Matthew","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouke Catherine","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep Chaitanya","family":"Vedithi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Saunderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Cauchoix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Cambau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2026.101514_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0362-3319(01)00116-1","article-title":"People with leprosy (Hansen\u2019s disease) during the Middle Ages","volume":"38","author":"Covey","year":"2001","journal-title":"Soc Sci J"},{"key":"10.1016\/j.lanmic.2026.101514_bib2","first-page":"429","article-title":"Global leprosy (Hansen disease) update, 2021: moving towards interruption of transmission","volume":"97","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.lanmic.2026.101514_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/17441692.2024.2354777","article-title":"Scrutinising delay in leprosy diagnosis in Colombia: perceptions and experiences by leprosy health professionals","volume":"19","author":"Duighuisen","year":"2024","journal-title":"Glob Public Health"},{"key":"10.1016\/j.lanmic.2026.101514_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmen.0000140","article-title":"Neglect of mental health issues and lack of integration of psychosocial interventions in Zero Leprosy Roadmaps: a critical oversight","volume":"1","author":"Fastenau","year":"2024","journal-title":"PLoS Ment Health"},{"key":"10.1016\/j.lanmic.2026.101514_bib5","first-page":"365","article-title":"Global leprosy (Hansen disease) update, 2024: beyond zero cases\u2014what elimination of leprosy really means","volume":"100","year":"2025","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.lanmic.2026.101514_bib6","doi-asserted-by":"crossref","first-page":"e1017","DOI":"10.1016\/S2214-109X(24)00062-7","article-title":"Post-exposure prophylaxis in leprosy (PEOPLE): a cluster randomised trial","volume":"12","author":"Hasker","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.lanmic.2026.101514_bib7","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1056\/NEJMoa2205487","article-title":"Single-dose rifapentine in household contacts of patients with leprosy","volume":"388","author":"Wang","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2026.101514_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006910","article-title":"Trend analysis of leprosy in Morocco between 2000 and 2017: evidence on the single dose rifampicin chemoprophylaxis","volume":"12","author":"Khoudri","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanmic.2026.101514_bib10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12879-018-3402-4","article-title":"An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP+","volume":"18","author":"Mieras","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101514_bib11","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S2214-109X(20)30396-X","article-title":"Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme","volume":"9","author":"Richardus","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.lanmic.2026.101514_bib12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12879-024-09125-2","article-title":"The PEP++ study protocol: a cluster-randomised controlled trial on the effectiveness of an enhanced regimen of post-exposure prophylaxis for close contacts of persons affected by leprosy to prevent disease transmission","volume":"24","author":"Hinders","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101514_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046125","article-title":"PEP4LEP study protocol: integrated skin screening and SDR-PEP administration for leprosy prevention: comparing the effectiveness and feasibility of a community-based intervention to a health centre-based intervention in Ethiopia, Mozambique and Tanzania","volume":"11","author":"Schoenmakers","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.lanmic.2026.101514_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40249-016-0140-y","article-title":"Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy","volume":"5","author":"Mieras","year":"2016","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.lanmic.2026.101514_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41467-017-02576-z","article-title":"Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae","volume":"9","author":"Benjak","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.lanmic.2026.101514_bib16","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.cmi.2018.02.022","article-title":"Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009\u201315","volume":"24","author":"Cambau","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.lanmic.2026.101514_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jgar.2022.08.021","article-title":"Global prevalence of resistance to rifampicin in Mycobacterium leprae: a meta-analysis","volume":"31","author":"Wang","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.lanmic.2026.101514_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jgar.2022.05.015","article-title":"Risk factors for dapsone resistance in leprosy patients: a systematic meta-analysis","volume":"30","author":"Wu","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.lanmic.2026.101514_bib19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jgar.2023.10.006","article-title":"High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: an indication to revisit second line anti-leprosy treatment regimen","volume":"35","author":"Chhabra","year":"2023","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.lanmic.2026.101514_bib20","article-title":"A case of fluoroquinolone-resistant leprosy discovered after 9 years of misdiagnosis","volume":"2016","author":"Raharolahy","year":"2016","journal-title":"Case Rep Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101514_bib21","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1016\/S2666-5247(22)00117-3","article-title":"Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study","volume":"3","author":"Marijke Braet","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2026.101514_bib22","article-title":"Molecular detection of mutations in the gyrA gene associated with fluoroquinolone resistance in Mycobacterium leprae strains from leprosy patients in Adzop\u00e9, C\u00f4te d\u2019Ivoire","volume":"96","author":"Roger","year":"2025","journal-title":"Lepr Rev"},{"key":"10.1016\/j.lanmic.2026.101514_bib23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12879-023-08290-0","article-title":"Protocol, rationale and design of BE-PEOPLE (bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts","volume":"23","author":"Younoussa","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101514_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02170-21","article-title":"Antimicrobial resistance among leprosy patients in Brazil: real-world data based on the national surveillance plan","volume":"66","author":"Andrade","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2026.101514_bib28","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa2212537","article-title":"Treatment strategy for rifampin-susceptible tuberculosis","volume":"388","author":"Paton","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2026.101514_bib29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/lungindia.lungindia_451_15","article-title":"Multidrug-resistant tuberculosis and leprosy: an unsolved mystery","volume":"34","author":"Gupta","year":"2017","journal-title":"Lung India"},{"key":"10.1016\/j.lanmic.2026.101514_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7861\/clinmedicine.14-3-279","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges","volume":"14","author":"G\u00fcnther","year":"2014","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.lanmic.2026.101514_bib33","first-page":"501","article-title":"Global leprosy (Hansen disease) update, 2023: elimination of leprosy disease is possible\u2013time to act!","volume":"99","year":"2024","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.lanmic.2026.101514_bib35","first-page":"409","article-title":"Global leprosy (Hansen disease) update, 2022: new paradigm\u2013control to elimination","volume":"98","year":"2023","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.lanmic.2026.101514_bib36","first-page":"421","article-title":"Global leprosy (Hansen disease) update, 2020: impact of COVID-19 on global leprosy control","volume":"96","year":"2021","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.lanmic.2026.101514_bib37","first-page":"417","article-title":"Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives","volume":"95","year":"2020","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.lanmic.2026.101514_bib38","first-page":"389","article-title":"Global leprosy update, 2018: moving towards a leprosy-free world","volume":"94","year":"2019","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.lanmic.2026.101514_bib39","first-page":"445","article-title":"Global leprosy update, 2017: reducing the disease burden due to leprosy","volume":"93","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.lanmic.2026.101514_bib40","first-page":"501","article-title":"Global leprosy update, 2016: accelerating reduction of disease burden","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.lanmic.2026.101514_bib41","article-title":"Drug resistance (dapsone, rifampicin, ofloxacin) and resistance-related gene mutation features in leprosy patients: a systematic review and meta-analysis","volume":"23","author":"Li","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"suppl 1","key":"10.1016\/j.lanmic.2026.101514_bib42","article-title":"The supply chain workforce: the foundation of health supply chains","volume":"13","author":"Zwinkels","year":"2025","journal-title":"Glob Health Sci Pract"},{"key":"10.1016\/j.lanmic.2026.101514_bib43","article-title":"Integration of tuberculosis services within primary health care: converting challenges into opportunities","volume":"1","author":"Pai","year":"2025","journal-title":"Lancet Prim Care"},{"key":"10.1016\/j.lanmic.2026.101514_bib44","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12889-023-15313-7","article-title":"Public health emergency preparedness for infectious disease emergencies: a scoping review of recent evidence","volume":"23","author":"Lee","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.lanmic.2026.101514_bib45","first-page":"68","article-title":"Expanding molecular diagnostic capacity for COVID-19 in Ethiopia: operational implications, challenges and lessons learnt","volume":"38","author":"Kebede","year":"2021","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.lanmic.2026.101514_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijmmb.2022.09.009","article-title":"Indian microbiology EQAS registered laboratory's capacity building and infection control practices during the COVID-19 pandemic in India: lessons learnt and gaps identified","volume":"43","author":"Murugesan","year":"2023","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.lanmic.2026.101514_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001739","article-title":"Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test","volume":"6","author":"Cambau","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanmic.2026.101514_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104649","article-title":"Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-Lep","volume":"93","author":"Jouet","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lanmic.2026.101514_bib52","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3389\/fmicb.2020.00711","article-title":"Population genomics of Mycobacterium leprae reveals a new genotype in Madagascar and the Comoros","volume":"11","author":"Avanzi","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.lanmic.2026.101514_bib54","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/ijd.17485","article-title":"Exploring the therapeutic and prophylactic potential of bedaquiline in leprosy","volume":"64","author":"Khera","year":"2025","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.lanmic.2026.101514_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005598","article-title":"Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases","volume":"11","author":"Stefani","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanmic.2026.101514_bib56","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1016\/S1473-3099(17)30314-6","article-title":"Innovative tools and approaches to end the transmission of Mycobacterium leprae","volume":"17","author":"Steinmann","year":"2017","journal-title":"Lancet Infect Dis"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524726001692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524726001692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:04:29Z","timestamp":1790690669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524726001692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"alternative-id":["S2666524726001692"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101514","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial resistance surveillance: a crucial pillar for sustainable leprosy control and chemoprophylaxis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101514"}}